Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Nov;35(11):e15898.
doi: 10.1111/dth.15898. Epub 2022 Oct 10.

Purpuric dermatosis and lymphocytic vasculopathy following SARS-CoV-2 vaccination: Report of two patients

Zahra Saffarian  1   2 , Rana Samii  2 , Alireza Hadizadeh  3 , Alireza Ghanadan  4 , Hassan Vahidnezhad  5   6
Affiliations
Case Reports

Purpuric dermatosis and lymphocytic vasculopathy following SARS-CoV-2 vaccination: Report of two patients

Zahra Saffarian et al. Dermatol Ther. 2022 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Purpuric dermatosis and lymphocytic vasculopathy after SARS‐CoV‐2 vaccination in Patients 1–2 (A) (left) In Patient 1, there are deep‐seated erythematous nodules and plaques with histopathology (right) of mild perivascular lymphocytic infiltration with extravasation of erythrocytes in the superficial and mid‐dermis with no evidence of intravascular thrombosis (B) In Patient 2 (left) non‐blanchable purpuric plaques were noted with histopathology of (right) moderate superficial perivascular lymphocytic infiltration with microhemorrhage, consistent with lymphocytic vasculopathy
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Saffarian Z, Samii R, Ghanadan A, Vahidnezhad H. De novo severe pemphigus vulgaris following SARS‐CoV‐2 vaccination with BBIBP‐CorV. Dermatol Ther. 2022;35(6):e15448. - PMC - PubMed
    1. Jorizzo JL. Classification of vasculitis. J Invest Dermatol. 1993;100(1):106s‐110s. - PubMed
    1. Seshan S. Lupus vasculopathy and Vasculitis: what is the difference and when do they occur? Pathol Case Rev. 2007;12:214‐221.
    1. Jamshidi P, Hajikhani B, Mirsaeidi M, Vahidnezhad H, Dadashi M, Nasiri MJ. Skin manifestations in COVID‐19 patients: are they indicators for disease severity? A systematic review. Front Med (Lausanne). 2021;8:634208. - PMC - PubMed
    1. Falkenhain‐López D, Gutiérrez‐Collar C, Arroyo‐Andrés J, Gallego‐Gutiérrez I, Rodríguez‐Peralto JL, Sánchez‐Velázquez A. Widespread purpura annularis telangiectodes following mRNA SARS‐CoV‐2 vaccine. J Eur Acad Dermatol Venereol. 2021;35(11):e719‐e721. - PMC - PubMed

Substances